Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Access2
A new study highlights GPT-4’s prowess, outperforming a radiology resident in medical imaging diagnostics. In the rapidly evolving field of medical imaging, artificial intelligence (AI) technologies, particularly generative models like the ChatGPT, are becoming increasingly significant.
New research shows pregnant women face higher risks and increased susceptibility to long-term COVID, with potential in-utero effects.
Recent studies suggest nerve decompression surgery is a promising option for treating chronic migraines, offering new hope to sufferers.
Explore the latest breakthroughs in HIV treatment, including advancements in antiretroviral therapy (ART), stem cell therapy, and gene editing, offering new hope for patients.
Recent studies have found that not all forms of exercise yield equal benefits. Specifically, recent studies suggest that occupational PA might have unexpected consequences for cognitive function. In this article, we delve into the research, exploring why occupational PA could potentially impact our brains differently.
USC’s Viterbi School of Engineering is revolutionising GI health monitoring for the future by introducing smart pills as a noninvasive,…
A recent publication in JAMA Ophthalmology has brought to light potential risks associated with the use of semaglutide, a medication often prescribed for managing type 2 diabetes (T2D) and obesity.
Recent advances reveal that an epilepsy drug may reverse Alzheimer’s symptoms, paving the way for innovative dementia treatments.
Roche announced today that Tecentriq® SC (atezolizumab) has been approved by the Singapore Health Sciences Authority (HSA) for all indications in which the intravenous (IV) formulation of Tecentriq has been previously approved, including certain types of lung, breast and liver cancer.4 Tecentriq SC is Roche’s fourth subcutaneous cancer therapy,5-7 and the world’s first injectable anti-PD-(L)1 cancer immunotherapy.
How does artemisinin, a compound from Traditional Chinese Medicine (TCM) plant Artemisia get involved with PCOS management? It has been shown to be able to modulate testosterone and insulin.
Subscribe to Updates
Subscribe to receive latest health related news from us
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.